Oct 1, 2024 06:00AM
Nov 4, 2022 04:03PM
Nov 4, 2022 04:01PM
Aug 31, 2021 09:19AM
Mar 16, 2021 01:30PM
Feb 18, 2021 04:01PM
Dec 15, 2020 04:16PM Gilead Sciences (GILD), Galapagos NV (GLPG) Amend Development Agreement for Jyselec
Dec 15, 2020 04:15PM
Nov 5, 2020 04:01PM
Sep 15, 2020 01:01PM
Aug 25, 2020 04:57AM
Aug 19, 2020 09:42AM
Aug 19, 2020 09:26AM
Aug 19, 2020 06:11AM Galapagos (GLPG) announces Gilead (GILD) received CRL for filgotinib for treatment of moderately to severely active rheumatoid arthritis
Aug 19, 2020 06:10AM
Aug 18, 2020 07:25PM
Jun 10, 2020 12:58PM
Jun 5, 2020 04:02PM
Jun 5, 2020 04:01PM
Jun 5, 2020 04:01PM
May 20, 2020 04:03PM Gilead Sciences (GILD), Galapagos NV (GLPG) Phase 2B/3 Trial of Filgotinib Met All Primary Endpoints
May 20, 2020 04:03PM
May 20, 2020 04:01PM
Jan 29, 2020 02:00AM
Dec 19, 2019 04:30PM
Nov 9, 2019 04:30PM
Nov 9, 2019 04:30PM
Oct 31, 2019 04:46PM Gilead Sciences (GILD), Galapagos (GLPG) to Present New Data on Filgotinib at 2019 ACR/ARP Annual Meeting
Oct 31, 2019 04:01PM
Oct 31, 2019 04:01PM
Oct 28, 2019 04:45PM
Oct 11, 2019 06:04AM
Oct 10, 2019 06:00PM
Oct 10, 2019 06:00PM
Aug 7, 2019 04:05PM Proteostasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Jul 25, 2019 04:02PM
Jul 23, 2019 07:00AM
Jul 14, 2019 02:53PM
Jul 2, 2019 01:01AM
Jun 11, 2019 06:10AM
Jun 11, 2019 01:01AM
May 29, 2019 04:31PM GILEAD AND GALAPAGOS TO PRESENT LATEST DATA ON FILGOTINIB AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY (EULAR 2019)
Apr 23, 2019 04:15PM
Apr 23, 2019 04:02PM
Jan 29, 2019 06:22AM
Dec 17, 2018 04:24PM
Dec 17, 2018 04:20PM
Nov 27, 2018 04:23PM
Nov 27, 2018 04:23PM Galapagos receives Fast Track designation from FDA for GLPG1972/S201086 in osteoarthritis
Sep 13, 2018 09:17AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All